Accuray Incorporated
LSE: 0H8I.L0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- London Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Equipment & Services
- CEO
- Stephen R. LaNeve
- Employees
- 987
- Headquarters
- Madison, United States
- IPO year
- 2018
- Market cap
- $39.2M
- Website
- https://www.accuray.com
Loading 0H8I…
Loading profile data…Frequently asked questions about 0H8I
What does Accuray Incorporated (0H8I.L) do?
Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the Americas, Europe, the Middle East, India, Africa, Japan, China, and rest of the Asia Pacific region. It offers the CyberKnife System, a robotic stereotactic radiosurgery and stereotactic body radiation the...
Where does 0H8I.L trade?
Accuray Incorporated (0H8I.L) trades on the London Stock Exchange.
What sector is 0H8I.L in?
Accuray Incorporated (0H8I.L) operates in the Healthcare sector, specifically in the Medical - Equipment & Services industry.
Who is the CEO of Accuray Incorporated?
Stephen R. LaNeve is the chief executive officer of Accuray Incorporated (0H8I.L).
Where is Accuray Incorporated headquartered?
Accuray Incorporated is headquartered in United States.
Does 0H8I.L pay a dividend?
Accuray Incorporated (0H8I.L) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 0H8I.L go public?
Accuray Incorporated (0H8I.L) completed its initial public offering in 2018.